Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 29, 2022 16:01 ET | Source: TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals Announces Closing of $12.3 Million Public Offering

FORT WORTH, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
November 29, 2022 16:01 ET | Source: Aspira Women's Health Inc.

Aspira Women’s Health Announces the Commercial Launch of OvaWatch(SM)

AUSTIN, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, announced the commercial launch...
November 29, 2022 16:01 ET | Source: X4 Pharmaceuticals

X4 Pharmaceuticals Announces Positive Top-Line Results from 4WHIM Global, Pivotal Phase 3 Trial of Once-Daily, Oral Mavorixafor in WHIM Syndrome

4WHIM trial meets primary endpoint and first key secondary endpoint, with mavorixafor achieving statistically significant and clinically relevant longer times above threshold levels for both absolute...
November 29, 2022 16:01 ET | Source: Taysha Gene Therapies, Inc.

Taysha Gene Therapies to Participate in JMP Securities Hematology and Oncology Summit

DALLAS, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene...
November 29, 2022 16:01 ET | Source: ACV

ACV to Participate at the 2022 Raymond James Technology Investors Conference

BUFFALO, N.Y., Nov. 29, 2022 (GLOBE NEWSWIRE) -- ACV (NASDAQ: ACVA), the leading online automotive marketplace for dealers, announced today that members of its management team will present at the...
November 29, 2022 16:01 ET | Source: Voyager Therapeutics, Inc.

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, has...
November 29, 2022 16:00 ET | Source: Viemed Healthcare, Inc.

Viemed Announces New Senior Secured Credit Facilities

LAFAYETTE, La., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home...
November 29, 2022 15:30 ET | Source: Allogene Therapeutics, Inc.

Allogene Therapeutics R&D Showcase Features Hematologic and Solid Tumor Advances Across its AlloCAR T™ Platform

Hematology Franchise: Lead CD19 and BCMA Programs Demonstrated Deep, Durable Responses CD19 Program: Phase 1 Studies Support Ongoing ALLO-501A Potentially Pivotal Phase 2 Trial in Relapsed/Refractory...
November 29, 2022 14:00 ET | Source: First Citizens Bank

First Citizens Bank’s 2022 Holiday Campaign Celebrates Teen Cancer America’s 10th Anniversary

RALEIGH, N.C., Nov. 29, 2022 (GLOBE NEWSWIRE) -- To honor Teen Cancer America’s (TCA) 10th anniversary of helping teens and young adults with cancer, First Citizens Bank is encouraging everyone to...
November 29, 2022 13:49 ET | Source: Sumo Logic, Inc.

Sumo Logic Accelerates Data Insights to Modernize Security Operations

LAS VEGAS, Nov. 29, 2022 (GLOBE NEWSWIRE) -- AWS re: Invent 2022 -- Sumo Logic (NASDAQ: SUMO), the SaaS analytics platform to enable reliable and secure cloud-native applications, today announced...